TimesSquare Capital Management »

Day One Biopharmaceuticals I shares owned by TimesSquare Capital Management

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by TimesSquare Capital Management from 13F filings

Historical chart of TimesSquare Capital Management investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by TimesSquare Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by TimesSquare Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $24M 1.7M 14.60
2023-09-30 $14M 1.1M 12.27
2023-06-30 $9.6M 806k 11.94

More positions owned by TimesSquare Capital Management

Cintas Corporation (CTAS)
Cyber-ark Software SHS (CYBR)
O'reilly Automotive (ORLY)
Hexcel Corporation (HXL)
Crowdstrike Holdings Cl A (CRWD)
Bj's Wholesale Club Holdings (BJ)
Gartner (IT)
AmerisourceBergen (COR)
Chemed Corp Com Stk (CHE)
Waste Connections (WCN)
Ascendis Pharma A/s Sponsored Adr (ASND)
Smartsheet Com Cl A (SMAR)
Cheniere Energy Com New (LNG)
Veeva Systems Cl A Com (VEEV)
Dex (DXCM)

View all positions for TimesSquare Capital Management

Top funds holding Day One Biopharmaceuticals I

RA Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
Franklin Resources
Braidwell
Viking Global Investors
T. Rowe Price Associates
Goldman Sachs Group
Deerfield Management Company
First Turn Management
Henderson Group
TimesSquare Capital Management
Partner Fund Management
Boxer Capital
Baker Bros. Advisors

View all funds holding Day One Biopharmaceuticals I